BioHarvest Sciences Inc.
BHST
$1.95
$0.042.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.95% | -12.96% | 25.44% | 6.55% | -493.89% |
| Total Depreciation and Amortization | 20.88% | 7.27% | 26.98% | 9.69% | 14.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.13% | 64.67% | 73.06% | 33.50% | 292.80% |
| Change in Net Operating Assets | -426.82% | -18.18% | -303.17% | -3,100.00% | -0.29% |
| Cash from Operations | -91.69% | 3.36% | 5.73% | -18.87% | -51.98% |
| Capital Expenditure | 4.05% | 13.30% | -66.41% | 16.99% | 65.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -25,100.00% | -100.00% | -100.00% | 100.00% |
| Cash from Investing | 4.05% | -134.26% | -67.00% | 9.96% | 69.37% |
| Total Debt Issued | -- | -- | -38.66% | -- | -- |
| Total Debt Repaid | -112.89% | -219.00% | -549.33% | -158.54% | -115.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -128.29% | -126.91% | 508.92% | 6,036.59% | -48.20% |
| Foreign Exchange rate Adjustments | 750.00% | -1,050.00% | 183.72% | 480.00% | -170.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,313.50% | -481.60% | 3,290.21% | 401.63% | -81.18% |